Independent drug studies are under threat in Canada, say researchers whose access to government databases on drug safety and efficacy has been suspended. Paul Webster reports in the November 24, 2012 issue of the Lancet. The...
The TI has come under attack in recent years for daring to stand up not only to the pharmaceutical industry, but to the whole system that is failing to protect the public. The system is...
A hard-hitting editorial published in today's BMJ by Fiona Godlee, BMJ Editor in chief, raises the call for clinical trial data for all drugs in current use to be made available for independent scrutiny. The article begins with...
When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclusive findings go unreported, leaving doctors...